Patient Navigation for HER2+ Metastatic Breast Cancer Patients Treated With Tucatinib
Patient Navigation for HER2+ Metastatic Breast Cancer Patients Treated With Tucatinib
Recruiting · NCT06983691 · Registry updated 2026-09-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Patient Navigation for HER2+ Metastatic Breast Cancer Patients Treated With Tucatinib | HER2+ Metastatic Breast Cancer (MBC) | Recruiting | Not applicable | 2026-09-08 | NCT06983691 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Duke University | 446 |
| Pfizer | 431 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Duke Cancer Institute | Durham | United States | 47 |